Have a personal or library account? Click to login
Mortality predictors in patients with ST-segment elevation myocardial infarction presenting no-reflow phenomenon after primary PCI: experience of a tertiary center Cover

Mortality predictors in patients with ST-segment elevation myocardial infarction presenting no-reflow phenomenon after primary PCI: experience of a tertiary center

Romanian Journal of Internal Medicine
Volume 63 (2025): Issue 4 (December 2025)
By: Larisa Renata Pantea-Roșan,  Ovidiu Țica,  Otilia Anca Țica,  Mircea Ioachim Popescu,  Iulia Bogdan,  Alexandra Buzle,  Mădălina Ioana Moisi and  Vlad Alin Pantea  
Open Access
|Aug 2025

References

  1. ALABAS O.A., JERNBERG T., PUJADES-RODRIGUEZ M., RUTHERFORD M.J., WEST R.M., HALL M., TIMMIS A., LINDAHL B., FOX K.A.A., HEMINGWAY H., GALE C.P. Statistics on mortality following acute myocardial infarction in 842,897 Europeans. Cardiovasc Res. 2020; 116(1):149–157.
    Search in Google ScholarBack to article
  2. THYGESEN K., ALPERT J.S., JAFFE A.S., CHAITMAN B.R., BAX J.J., MORROW D.A., WHITE H.D. AND THE EXECUTIVE GROUP ON BEHALF OF THE JOINT EUROPEAN SOCIETY OF CARDIOLOGY (ESC)/AMERICAN COLLEGE OF CARDIOLOGY (ACC)/AMERICAN HEART ASSOCIATION (AHA)/WORLD HEART FEDERATION (WHF) TASK FORCE FOR THE UNIVERSAL DEFINITION OF MYOCARDIAL INFARCTION. Fourth Universal Definition of Myocardial Infarction. Circulation. 2018; 138(20):e618–e65.
    Search in Google ScholarBack to article
  3. ASHRAF T., KHAN M.N., AFAQUE S.M., AAMIR K.F., KUMAR M., SAGHIR T., RASOOL S.I., et al. Clinical and procedural predictors and short-term survival of the patients with no reflow phenomenon after primary percutaneous coronary intervention. Int J Cardiol. 2019; pii: S0167-5273(19)32691-9.
    Search in Google ScholarBack to article
  4. TATU-CHIȚOIU G., TATU-CHIȚOIU A., LĂCĂU S. Electrocardiograma în reperfuzia miocardică. București (RO): Edit. Medicală Antaeus; 2014.
    Search in Google ScholarBack to article
  5. NAIR RAJESH G., JAYAPRASAD N., MADHAVAN S., SUDHA KUMARY V., JAYAPRAKASH K., et al. Predictors and prognosis of no-reflow during primary percutaneous coronary intervention. Proc (Bayl Univ Med Cent). 2018; 32(1):30–33.
    Search in Google ScholarBack to article
  6. AL AZZONI A.M., LAMELAS P., MARSDEN T., DZAVIK V., CAIRNS J., MEEKS B., et al. Incidence and predictors of no reflow phenomenon: insights from the total trial. Journal of the American College of Cardiology. 2017; 69(11); Suppl1179.
    Search in Google ScholarBack to article
  7. IBANEZ B., JAMES S., AGEWALL S., ANTUNES M.J., BUCCIARELLI-DUCCI C., BUENO H., et al. ESC Scientific Document Group. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2018; 39(2):119–177.
    Search in Google ScholarBack to article
  8. HARRISON R.W., AGGARWAL A., OU F.S., KLEIN L.W., RUMSFELD J.S., ROE M.T., WANG T.Y. Incidence and outcomes of no-reflow phenomenon during percutaneous coronary intervention among patients with acute myocardial infarction. Am J Cardiol. 2013;111(2):178–84.
    Search in Google ScholarBack to article
  9. NICCOLI G., COSENTINO N., SPAZIANI C., FRACASSI F., TARANTINI G., CREA F. No-reflow: incidence and detection in the cath-lab. Curr Pharm Des. 2013;19(25):4564–75.
    Search in Google ScholarBack to article
  10. SINUSAS A.J. Noninvasive Evaluation of No-Reflow Phenomenon. Circulation: Cardiovascular Imaging. 2018; 11(11):e008576.
    Search in Google ScholarBack to article
  11. VEROUDEN N.J., HAECK J.D., KOCH K.T., HENRIQUES J.P., BAAN J., VAN DER SCHAAF R.J., et al. ST-segment resolution prior to primary percutaneous coronary intervention is a poor indicator of coronary artery patency in patients with acute myocardial infarction. Ann Noninvasive Electrocardiol. 2010;15(2):107–15.
    Search in Google ScholarBack to article
  12. OIKONOMOU E., MOUROUZIS K., VOGIATZI G., SIASOS G., DEFTEREOS S., PAPAIOANNOU S., et al. Coronary Microcirculation and the No-reflow Phenomenon. Curr Pharm Des. 2018;24(25):2934–2942.
    Search in Google ScholarBack to article
  13. ITO H. No-reflow phenomenon and prognosis in patients with acute myocardial infarction. Nat Clin Pract Cardiovasc Med. 2006;3(9):499–506.
    Search in Google ScholarBack to article
  14. BOULETI C., MEWTON N., GERMAIN S. The no-reflow phenomenon: State of the art. Arch Cardiovasc Dis. 2015;108(12):661–74.
    Search in Google ScholarBack to article
  15. HARRISON R.W., AGGARWAL A., OU F.S., KLEIN L.W., RUMSFELD J.S., ROE M.T., WANG T.Y. Incidence and outcomes of no-reflow phenomenon during percutaneous coronary intervention among patients with acute myocardial infarction. Am J Cardiol. 2013;111(2):178–84.
    Search in Google ScholarBack to article
  16. JYOTSNA M., NEMANI L. No-Reflow. Ind J Car Dis Wom. 2017; 02(01): 082–098.
    Search in Google ScholarBack to article
  17. HUTCHINS K.D., SKURNICK J., LAVENHAR M., NATARAJAN G.A. Cardiac rupture in acute myocardial infarction: a reassessment. Am J Forensic Med Pathol. 2002;23(1):78–82.
    Search in Google ScholarBack to article
  18. UENO D., NOMURA T., ONO K., SAKAUE Y., HORI Y., YOSHIOKA K., KIKAI M., KEIRA N., TATSUMI T. Fatal Right Ventricular Free Wall Rupture During Percutaneous Coronary Intervention for Inferior Acute Myocardial Infarction. Am J Case Rep. 2019;20:1155–1158.
    Search in Google ScholarBack to article
  19. AZEVEDO P.S., POLEGATO B.F., MINICUCCI M.F., PAIVA S.A.R., ZORNOFF L.A.M. Cardiac Remodeling: Concepts, Clinical Impact, Pathophysiological Mechanisms and Pharmacologic Treatment. Arq Bras Cardiol. 2016; 106(1): 62–69.
    Search in Google ScholarBack to article
  20. FRENCH B.A., KRAMER C.M. Mechanisms of Post-Infarct Left Ventricular Remodeling. Drug Discov Today Dis Mech. 2007; 4(3): 185–196.
    Search in Google ScholarBack to article
  21. MORISHIMA I., SONE T., OKUMURA K., TSUBOI H., KONDO J., MUKAWA H., MATSUI H., TOKI Y., ITO T., HAYAKAWA T. Angiographic no-reflow phenomenon as a predictor of adverse long-term outcome in patients treated with percutaneous transluminal coronary angioplasty for first acute myocardial infarction. J Am Coll Cardiol. 2000;36(4):1202–9.
    Search in Google ScholarBack to article
  22. YONG A.S.C., FEARON W.F. Assessing the Coronary Microcirculation in Patients After Primary Percutaneous Coronary Intervention. J Am Heart Assoc. 2018; 7(15): e009828.
    Search in Google ScholarBack to article
  23. ARMSTRONG R., DE MARIA G.L., SCARSINI R., BANNING A.P. Assessing and managing coronary microcirculation dysfunction in acute ST-segment elevation myocardial infarction. Expert Rev Cardiovasc Ther. 2019;17(2):111–126.
    Search in Google ScholarBack to article
  24. YONG A.S., FEARON W.F. Coronary microvascular dysfunction after ST-segment-elevation myocardial infarction: local or global phenomenon?. Circ Cardiovasc Interv. 2013;6(3):201–3.
    Search in Google ScholarBack to article
  25. BEKKERS S.C., YAZDANI S.K., VIRMANI R., WALTENBERGER J. Microvascular obstruction: underlying pathophysiology and clinical diagnosis. J Am Coll Cardiol. 2010;55(16):1649–60.
    Search in Google ScholarBack to article
  26. SCHWARTZ R.S., BURKE A., FARB A., KAYE D., LESSER J.R., HENRY T.D., VIRMANI R. Microemboli and microvascular obstruction in acute coronary thrombosis and sudden coronary death: relation to epicardial plaque histopathology. J Am Coll Cardiol. 2009;54(23):2167–73.
    Search in Google ScholarBack to article
  27. REINDL M., REINSTADLER S.J., FEISTRITZER H.J., KLUG G., TILLER C., MAIR J., MAYR A., JASCHKE W., METZLER B. Relation of inflammatory markers with myocardial and microvascular injury in patients with reperfused ST-elevation myocardial infarction. Eur Heart J Acute Cardiovasc Care. 2017;6(7):640–64.
    Search in Google ScholarBack to article
  28. VRINTS C.J. Pathophysiology of the no-reflow phenomenon. Acute Card Care. 2009;11(2):69–76.
    Search in Google ScholarBack to article
  29. NICCOLI G., SCALONE G., LERMAN A., CREA F. Coronary microvascular obstruction in acute myocardial infarction. Eur Heart J. 2016;37(13):1024–33.
    Search in Google ScholarBack to article
  30. ITO H. Etiology and clinical implications of microvascular dysfunction in patients with acute myocardial infarction. Int Heart J. 2014;55(3):185–9.
    Search in Google ScholarBack to article
  31. BELTRAME J.F. Coronary microvascular dysfunction in acute ST elevation myocardial infarction. Coronary Artery Disease. 2017; 28(1):3–4.
    Search in Google ScholarBack to article
  32. KHAN J.N., RAZVI N., NAZIR S.A., SINGH A., MASCA N.G., GERSHLICK A.H., SQUIRE I., MCCANN G.P. Prevalence and extent of infarct and microvascular obstruction following different reperfusion therapies in ST-elevation myocardial infarction. J Cardiovasc Magn Reson. 2014;16:38.
    Search in Google ScholarBack to article
  33. NICCOLI G., SCALONE G., LERMAN A., CREA F. Coronary microvascular obstruction in acute myocardial infarction. Eur Heart J. 2016;37(13):1024–33.
    Search in Google ScholarBack to article
  34. NAGAO M., HIGASHINO H., MATSUOKA H., KAWAKAMI H., MOCHIZUKI T., MURASE K., UEMURA M., KOUNO T. Clinical importance of microvascular obstruction on contrast-enhanced MRI in reperfused acute myocardial infarction. Circ J. 2008;72(2):200–4.
    Search in Google ScholarBack to article
  35. THYGESEN K. What’s new in the Fourth Universal Definition of Myocardial infarction? Eur Heart J. 2018;39(42):3757–3758.
    Search in Google ScholarBack to article
  36. LEE C.H., WONG H.B., TAN H.C., ZHANG J.J., TEO S.G., ONG H.Y., LOW A., SUTANDAR A., LIM Y.T. Impact of reversibility of no reflow phenomenon on 30-day mortality following percutaneous revascularization for ate myocardial infarction-insights from a 1328 patient registry. J Interv Cardiol. 2005;18(4):261–6.
    Search in Google ScholarBack to article
  37. ALABAS O.A., GALE C.P., HALL M., RUTHERFORD M.J., SZUMMER K., LAWESSON S.S., ALFREDSSON J., LINDAHL B., JERNBERG T. Sex Differences in Treatments, Relative Survival, and Excess Mortality Following Acute Myocardial Infarction: National Cohort Study Using the SWEDEHEART Registry. J Am Heart Assoc. 2017;6(12). pii: e007123.
    Search in Google ScholarBack to article
  38. SMILOWITZ N.R., MAHAJAN A.M., ROE M.T., HELLKAMP A.S., CHISWELL K., GULATI M., REYNOLDS H.R. Mortality of Myocardial Infarction by Sex, Age, and Obstructive Coronary Artery Disease Status in the ACTION Registry-GWTG (Acute Coronary Treatment and Intervention Outcomes Network Registry-Get with the Guidelines). Circ Cardiovasc Qual Outcomes. 2017;10(12):e003443.
    Search in Google ScholarBack to article
  39. SCHOLZ K.H., MAIER S.K.G., MAIER L.S., LENGENFELDER B., JACOBSHAGEN C., JUNG J., et al. Impact of treatment delay on mortality in ST-segment elevation myocardial infarction (STEMI) patients presenting with and without haemodynamic instability: results from the German prospective, multicentre FITT-STEMI trial. Eur Heart J. 2018;39(13):1065–1074.
    Search in Google ScholarBack to article
  40. KARWOWSKI J., GIERLOTKA M., GĄSIOR M., POLOŃSKI L., CISZEWSKI J., BĘĆKOWSKI M., KOWALIK I., SZWED H. Relationship between infarct artery location, acute total coronary occlusion, and mortality in STEMI and NSTEMI patients. Pol Arch Intern Med. 2017;127(6):401–411.
    Search in Google ScholarBack to article
  41. CHOO E.H., KIM P.J., CHANG K., AHN Y., JEON D.S., LEE J.M., et al. The impact of no-reflow phenomena after primary percutaneous coronary intervention: a time-dependent analysis of mortality. Coron Artery Dis. 2014;25(5):392–8.
    Search in Google ScholarBack to article
  42. KIM M.C., CHO J.Y., JEONG H.C., LEE K.H., PARK K.H., SIM D.S., et al. Long-Term Clinical Outcomes of Transient and Persistent No Reflow Phenomena following Percutaneous Coronary Intervention in Patients with Acute Myocardial Infarction. Korean Circ J. 2016;46(4):490–8.
    Search in Google ScholarBack to article
  43. JIECHENG P., AI-LING W. Clinical significance of no-reflow in different stages of primary angioplasty among patients with acute myocardial infarctions. Perfusion. 2016;31(4):300–6.
    Search in Google ScholarBack to article
  44. BADIMON L., VILAHUR G. Thrombosis formation on atherosclerotic lesions and plaque rupture. J Intern Med. 2014;276(6):618–32.
    Search in Google ScholarBack to article
  45. KAUL S. The “no reflow” phenomenon following acute myocardial infarction: mechanisms and treatment options. J Cardiol. 2014; 64(2):77–85.
    Search in Google ScholarBack to article
  46. PASOTTI M., PRATI F., ARBUSTINI E. The pathology of myocardial infarction in the pre- and post-interventional era. Heart. 2006; 92(11):1552–6.
    Search in Google ScholarBack to article
  47. BISOYI S., DASH A.K., NAYAK D., SAHOO S., MOHAPATRA R. Left ventricular pseudoaneurysm versus aneurysm a diagnosis dilemma. Ann Card Anaesth. 2016; 19(1):169–72.
    Search in Google ScholarBack to article
  48. ISKHAKOV M.M., TAGIROVA D.R., GAZIZOV N.V., NUGAYBEKOVA L.A., SAYFUTDINOV R.G. No-reflow phenomenon: clinical aspects of reperfusion failure. Kazan Medical Journal 2015; 96(3):391–396.
    Search in Google ScholarBack to article
  49. PANTEA-ROSAN L.R., PANTEA V.A., BUNGAU S., TIT D.M., BEHL T., VESA C.M., et al. No-reflow after PPCI – A predictor of short-term outcomes in STEMI patients. Journal of Clinical Medicine, 2020; 9(9):1–16.
    Search in Google ScholarBack to article
  50. SHAMSHAD F., KENCHAIAH S., FINN P.V., SOLER-SOLER J., MCMURRAY J.J., VELAZQUEZ E.J., MAGGIONI A.P., et al. Fatal myocardial rupture after acute myocardial infarction complicated by heart failure, left ventricular dysfunction, or both: the VALsartan In Acute myocardial iNfarcTion Trial (VALIANT). Am Heart J. 2010;160(1):145–51.
    Search in Google ScholarBack to article
  51. ȚICA O., ȚICA O., BUNTING K.V., DEBONO J., GKOUTOS G.V., POPESCU M.I., KOTECHA D. Post-mortem examination of high mortality in patients with heart failure and atrial fibrillation. BMC Med. 2022; 20(1):331.
    Search in Google ScholarBack to article
  52. JELAVIC M.M., ȚICA O., PINTARIC H., ȚICA O. Circulating Neuropeptide Y May Be a Biomarker for Diagnosing Atrial Fibrillation. Cardiology. 2023; 148(6):593–595.
    Search in Google ScholarBack to article
DOI: https://doi.org/10.2478/rjim-2025-0016 | Journal eISSN: 2501-062X | Journal ISSN: 1220-4749
Journal RSS Feed
Language: English
Page range: 265 - 276
Submitted on: May 19, 2025
|
Published on: Aug 28, 2025
Published by: N.G. Lupu Internal Medicine Foundation
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
myocardial infarction,
ST elevation myocardial infarction,
no-reflow phenomenon,
percutaneous coronary intervention,
mortality,
risk factors,
autopsy
Related subjects:
Medicine,
Clinical medicine,
Internal medicine,
Internal medicine, other,
Cardiology,
Gastroenterology,
Rheumatology

© 2025 Larisa Renata Pantea-Roșan, Ovidiu Țica, Otilia Anca Țica, Mircea Ioachim Popescu, Iulia Bogdan, Alexandra Buzle, Mădălina Ioana Moisi, Vlad Alin Pantea, published by N.G. Lupu Internal Medicine Foundation
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Volume 63 (2025): Issue 4 (December 2025)Next article